GENEVA (Reuters) - Nearly 60 million women will give birth without any medical assistance this year, the World Health Organization (WHO) said on Tuesday in a report calling for an overhaul of how health care is financed and managed globally.
CHICAGO (Reuters) - A long-term analysis of people who took the arthritis drug Vioxx confirms it doubles the risk of strokes and heart attacks, researchers said on Monday, but this risk goes away a year after people stop taking it.
CHICAGO (Reuters) - A study of nearly 40,000 women has found no overall link between caffeine and breast cancer, though some women who have benign breast lumps might be at a higher risk, researcher said on Monday.
LONDON (Reuters) - Britain's healthcare cost effectiveness watchdog NICE has rebuffed GlaxoSmithKline's latest bid to get its drug Tyverb - for women with advanced breast cancer - into the state health system, the company said on Tuesday.
CHICAGO (Reuters) - The American Academy of Pediatrics has doubled its recommendation for a daily dose of vitamin D in children in the hopes of preventing rickets and reaping other health benefits, the group said on Monday.
BRUSSELS (Reuters) - Millions of youngsters across Europe could suffer permanent hearing loss after five years if they listen to MP3 players at too high a volume for more than five hours a week, EU scientists warned Monday.
BEIJING (Reuters) - Three Chinese dairy companies have publicly apologized for their involvement in a toxic milk scandal that has killed at least four children and led to Chinese-made products pulled from shelves around the world.
NEW YORK (Reuters Health) - There is no evidence that probiotics can relieve the bothersome symptoms of eczema and there is some evidence that they may occasionally cause infections and gut problems, conclude researchers based on a review of the best available research on the topic.
WASHINGTON (Reuters) - A global AIDS vaccine conference this week will seek fresh strategies against the HIV virus, with experts weighing the value of basic laboratory research against large-scale human clinical trials after a string of disappointments.
LONDON (Reuters) - Scientists have found two new genetic variations that appear to increase the risk of the most common skin cancer among people of European descent.
WASHINGTON (Reuters) - Researchers trying to find ways to transform ordinary skin cells into powerful stem cells said on Sunday they found a shortcut by "sprinkling" a chemical onto the cells.
JOHANNESBURG (Reuters) - A disease that has killed three people in South Africa and forced others into isolation wards may be rodent borne, a health official said Sunday, SAPA news agency reported.
PRISTINA (Reuters) - Thousands of Kosovo doctors went on strike Monday in state hospitals after failing to reach a deal for better conditions and more money, a situation that left the sick untreated.
BEIJING (Reuters) - Some 170 wedding banquet guests were rushed to hospital in north China when powdered rust remover was added to the pot instead of salt after they all decided it needed added flavor, Chinese media said.
SULAIMANIYA, Iraq (Reuters) - Thirty-seven people have been infected by anthrax in northern Iraq in the country's first outbreak of the disease since the 1980s, the health minister in the Kurdish autonomous region said Sunday.
HONG KONG (Reuters) - French drugmaker Sanofi-Aventis hopes to sell 25 million doses of seasonal flu vaccine annually into China's largely untapped domestic market once its plant in the southern city of Shenzhen goes onstream in 2012.
LOS ANGELES (Reuters) - A magazine cover photo of Angelina Jolie breast-feeding one of her newborn twins may have turned the superstar actress into a role model for new mothers.
NEW YORK (Reuters Health) - People who undergo liver transplantation, particularly children, are at increased risk for developing cancer, Finnish researchers report in the journal Liver Transplantation.
Copyright © 2008 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.